- Home
- KRRO vs NATH Comparison
KRRO vs NATH Comparison
Compare KRRO & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- NATH
- Stock Information
- Founded
- KRRO 2014
- NATH 1916
- Country
- KRRO United States
- NATH United States
- Employees
- KRRO N/A
- NATH N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- KRRO Health Care
- NATH Consumer Discretionary
- Exchange
- KRRO Nasdaq
- NATH Nasdaq
- Market Cap
- KRRO 281.2M
- NATH 330.5M
- IPO Year
- KRRO 2019
- NATH N/A
- Fundamental
- Price
- KRRO $26.29
- NATH $100.10
- Analyst Decision
- KRRO Strong Buy
- NATH
- Analyst Count
- KRRO 7
- NATH 0
- Target Price
- KRRO $133.83
- NATH N/A
- AVG Volume (30 Days)
- KRRO 61.9K
- NATH 14.4K
- Earning Date
- KRRO 03-25-2025
- NATH 02-06-2025
- Dividend Yield
- KRRO N/A
- NATH 2.00%
- EPS Growth
- KRRO N/A
- NATH 24.88
- EPS
- KRRO N/A
- NATH 5.80
- Revenue
- KRRO N/A
- NATH $146,386,000.00
- Revenue This Year
- KRRO N/A
- NATH N/A
- Revenue Next Year
- KRRO N/A
- NATH N/A
- P/E Ratio
- KRRO N/A
- NATH $17.26
- Revenue Growth
- KRRO N/A
- NATH 6.83
- 52 Week Low
- KRRO $26.23
- NATH $64.02
- 52 Week High
- KRRO $98.00
- NATH $102.81
- Technical
- Relative Strength Index (RSI)
- KRRO 29.17
- NATH 76.91
- Support Level
- KRRO $28.90
- NATH $97.85
- Resistance Level
- KRRO $40.68
- NATH $102.50
- Average True Range (ATR)
- KRRO 2.26
- NATH 3.20
- MACD
- KRRO -0.36
- NATH 1.64
- Stochastic Oscillator
- KRRO 0.42
- NATH 87.68
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.